MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
AVROBIO EV/EBITDA 2011-2026 | AVRO
EV/EBITDA Jährlich AVROBIO
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.957 | -2.2 | -5.06 | -1.04 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.957 | -5.06 | -1.84 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K |  USA |
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Anika Therapeutics
ANIK
|
38.7 | $ 9.46 | 1.18 % | $ 139 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.25 | 2.85 % | $ 7.82 B |  Australia |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 10.01 | -7.66 % | $ 647 M | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 211.38 | -0.9 % | $ 5 B |  Danmark |
 |
Aclaris Therapeutics
ACRS
|
-9.24 | $ 2.62 | -9.2 % | $ 203 M | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 4.28 | -2.73 % | $ 9.31 B |  Israel |
 |
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | USA |
 |
BioNTech SE
BNTX
|
4.1 | $ 96.5 | -0.2 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 26.84 | 1.42 % | $ 1.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.81 | -3.21 % | $ 462 M | Britain |
 |
CASI Pharmaceuticals
CASI
|
-26.1 | $ 0.85 | 3.22 % | $ 116 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.34 | $ 11.08 | -0.05 % | $ 729 M | USA |
 |
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
BioVie
BIVI
|
-0.244 | $ 1.29 | -3.01 % | $ 1.91 M | USA |
 |
Axon Enterprise
AXON
|
-63.9 | $ 593.03 | 5.25 % | $ 44.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-1.92 | $ 2.9 | 4.69 % | $ 18.2 M | USA |
 |
AstraZeneca PLC
AZN
|
76.5 | $ 91.04 | -0.58 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | USA |
 |
bluebird bio
BLUE
|
-0.805 | - | - | $ 546 M | USA |
 |
Cellectis S.A.
CLLS
|
-1.37 | $ 4.56 | -5.1 % | $ 116 M | France |
 |
Biogen
BIIB
|
12.7 | $ 174.34 | -1.96 % | $ 25.4 B | USA |
 |
Cellectar Biosciences
CLRB
|
1.31 | $ 3.39 | -2.31 % | $ 41.4 M | USA |
 |
Abeona Therapeutics
ABEO
|
0.0546 | $ 5.23 | -1.6 % | $ 112 M | USA |